• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短期重组人促红细胞生成素治疗对预防极低出生体重儿早产儿贫血的作用。

Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.

作者信息

Yasmeen B H N, Chowdhury M A K A, Hoque M M, Hossain M M, Jahan R, Akhtar S

机构信息

Department of Pediatrics, Northern International Medical College, Dhanmondi, Dhaka.

出版信息

Bangladesh Med Res Counc Bull. 2012 Dec;38(3):119-23. doi: 10.3329/bmrcb.v38i3.14340.

DOI:10.3329/bmrcb.v38i3.14340
PMID:23540189
Abstract

Premature infants especially those with birth weight < 1500 g suffer from Anaemia of prematurity (AOP) and associated problems. Erythropoietin therapy is a safe effective way to prevent and to treat anaemia of prematurity. To evaluate the effect of short-term administration of recombinant human erythropoietin (rHuEPO) with iron and folic acid in very low birth weight (VLBW) neonates in the prevention of anaemia of prematurity. A randomized controlled trial was carried out at Dhaka Shishu Hospital. Sixty preterm very low birth weight (PTVLBW) babies were enrolled in this study. Thirty were assigned to rHuEPO group and 30 as control. Baseline haematologic values were estimated before administration of rHuEPO. From day 7 of life rHuEPO-200 IU/kg/dose subcutaneously every alternate day for 2 weeks was administered to rHuEPO group. All infants in both groups have received oral iron, folic acid from day 14. Clinical and haematological assessment was done at 6 and 10 weeks of life. Baseline clinical characteristics and haematologic values were almost similar in both groups. This study has shown increase in haematological values (haemoglobin and haematocrit) and reduction in the number of blood transfusions during both the 1st and 2nd follow up in rHuEPO group in comparison to control group (p < 0.01). Short-term rHuEPO appears to be very effective in prevention of Anaemia of prematurity.

摘要

早产儿尤其是出生体重<1500克的婴儿易患早产儿贫血(AOP)及相关问题。促红细胞生成素治疗是预防和治疗早产儿贫血的一种安全有效的方法。为评估短期给予重组人促红细胞生成素(rHuEPO)联合铁剂和叶酸对极低出生体重(VLBW)新生儿预防早产儿贫血的效果。在达卡儿童医院进行了一项随机对照试验。本研究纳入了60例早产极低出生体重(PTVLBW)婴儿。30例被分配到rHuEPO组,30例作为对照组。在给予rHuEPO之前评估基线血液学值。从出生第7天起,rHuEPO组每隔日皮下注射200 IU/kg/剂量,共2周。两组所有婴儿从第14天起均接受口服铁剂、叶酸。在出生6周和10周时进行临床和血液学评估。两组的基线临床特征和血液学值几乎相似。本研究表明,与对照组相比,rHuEPO组在第1次和第2次随访期间血液学值(血红蛋白和血细胞比容)升高,输血次数减少(p<0.01)。短期rHuEPO似乎对预防早产儿贫血非常有效。

相似文献

1
Effect of short-term recombinant human erythropoietin therapy in the prevention of anemia of prematurity in very low birth weight neonates.短期重组人促红细胞生成素治疗对预防极低出生体重儿早产儿贫血的作用。
Bangladesh Med Res Counc Bull. 2012 Dec;38(3):119-23. doi: 10.3329/bmrcb.v38i3.14340.
2
Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.给早产儿使用促红细胞生成素(重组人促红细胞生成素)治疗其贫血。
Pediatr Hematol Oncol. 1998 Jan-Feb;15(1):37-43. doi: 10.3109/08880019809009506.
3
Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.极低出生体重儿接受促红细胞生成素治疗以预防早产儿贫血后的随访
J Pediatr. 1995 Aug;127(2):291-7. doi: 10.1016/s0022-3476(95)70313-6.
4
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.早期使用促红细胞生成素预防早产和/或低出生体重儿的红细胞输血
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004863. doi: 10.1002/14651858.CD004863.pub2.
5
Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity.在早产儿贫血的促红细胞生成素治疗期间,尽管补充了铁剂,但铁蛋白水平仍降低。
Acta Paediatr. 1996 Apr;85(4):496-501. doi: 10.1111/j.1651-2227.1996.tb14070.x.
6
Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants.早期促红细胞生成素影响极低出生体重儿的输血需求和通气需求。
J Matern Fetal Neonatal Med. 2011 Aug;24(8):1060-4. doi: 10.3109/14767058.2010.545917. Epub 2011 Jan 21.
7
The effect of recombinant human erythropoietin in treating the anemia of prematurity.重组人促红细胞生成素治疗早产儿贫血的效果
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1995 Mar-Apr;36(2):121-7.
8
Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.早期与晚期给予重组人促红细胞生成素对早产儿输血需求的影响:一项随机、安慰剂对照、多中心试验的结果
Pediatrics. 2000 May;105(5):1066-72. doi: 10.1542/peds.105.5.1066.
9
The use of recombinant human erythropoietin in the treatment of anaemia of prematurity.重组人促红细胞生成素在治疗早产儿贫血中的应用。
Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):178-83.
10
Recombinant human erythropoietin in the treatment of anemia of prematurity.重组人促红细胞生成素治疗早产儿贫血
Am J Perinatol. 1995 Sep;12(5):314-8. doi: 10.1055/s-2007-994483.

引用本文的文献

1
Early erythropoiesis-stimulating agents in preterm or low birth weight infants.早产或低出生体重婴儿早期促红细胞生成素刺激剂
Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD004863. doi: 10.1002/14651858.CD004863.pub6.
2
Early erythropoiesis-stimulating agents in preterm or low birth weight infants.早产或低出生体重婴儿早期促红细胞生成素刺激剂
Cochrane Database Syst Rev. 2017 Nov 16;11(11):CD004863. doi: 10.1002/14651858.CD004863.pub5.
3
Association between anemia and bronchopulmonary dysplasia in preterm infants.早产儿贫血与支气管肺发育不良之间的关联。
Sci Rep. 2016 Mar 3;6:22717. doi: 10.1038/srep22717.
4
Postoperative outcome in premature infants with open abdomen.早产儿腹壁切开术后的结局。
Hernia. 2014 Jun;18(3):351-6. doi: 10.1007/s10029-014-1226-8. Epub 2014 Feb 8.